Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Chinese Patent Office
Colorcon
Cantor Fitzgerald
Chubb
Novartis
Fuji
Accenture
Moodys

Generated: February 21, 2018

DrugPatentWatch Database Preview

Sumatriptan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sumatriptan and what is the scope of sumatriptan freedom to operate?

Sumatriptan
is the generic ingredient in nine branded drugs marketed by Glaxosmithkline, Lannett Co Inc, Meridian Medcl, Antares Pharma Inc, Aurobindo Pharma Ltd, Dr Reddys Labs Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Injectalia, Mylan Asi, Mylan Labs Ltd, Par Pharm, Par Sterile Products, Sandoz Inc, Sun Pharma Global, Teva Parenteral, Teva Pharms Usa, West-ward Pharms Int, Wockhardt, Endo Ventures Ltd, Avanir Pharms, Dr Reddys Labs Ltd, Teva Branded Pharm, Apotex Inc, Aurobindo Pharma, Fosun Pharma, Hikma Pharms, Mylan, Orchid Hlthcare, Roxane, Sun Pharm Inds, Sun Pharm Inds Ltd, Teva, and Watson Labs, and is included in forty-one NDAs. There are thirty-three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for sumatriptan. Four suppliers are listed for this compound. There are seven tentative approvals for this compound.
Medical Subject Heading (MeSH) Categories for sumatriptan
Tentative approvals for SUMATRIPTAN
Applicant Application No. Strength Dosage Form
➤ Sign Up➤ Sign UpEQ 25MG BASETABLET;ORAL
➤ Sign Up➤ Sign UpEQ 100MG BASETABLET;ORAL
➤ Sign Up➤ Sign UpEQ 50MG BASETABLET;ORAL

US Patents and Regulatory Information for sumatriptan

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078295-001 Aug 10, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078241-002 Aug 10, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 BX RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Avanir Pharms ONZETRA XSAIL sumatriptan succinate POWDER;INHALATION 206099-001 Jan 27, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 078295-003 Aug 10, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm ZECUITY sumatriptan succinate SYSTEM;IONTOPHORESIS 202278-001 Jan 17, 2013 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 BX RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Mylan SUMATRIPTAN SUCCINATE sumatriptan succinate TABLET;ORAL 077744-002 Aug 10, 2009 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Injectalia SUMATRIPTAN SUCCINATE sumatriptan succinate INJECTABLE;SUBCUTANEOUS 090310-001 Aug 11, 2010 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for sumatriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-003 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-003 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
Accenture
Teva
Medtronic
Daiichi Sankyo
AstraZeneca
UBS
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot